Navigation Links
The Evermedia Group, Inc. Advances Corporate Transparency Efforts
Date:12/12/2011

seemingly inconsequential information that we desire to release to our shareholders and the investing public.  All allowable disclosures and non-sensitive information will continue to be posted, primarily on our website and social media platforms."

About The Evermedia Group, Inc.

The Evermedia Group, Inc. is a Service Disabled, Veteran Owned Small Business (SDVOSB) providing defense and security solutions to government agencies and private entities.  Evermedia Group's wholly-owned operating subsidiaries include defense contractor System Technology Solutions, Inc. and biometric technology developer Evermedia Biometrics Corporation. Follow Evermedia on Facebook (facebook.com/Evermedia) and Twitter (twitter.com/evermediagroup).

Safe Harbor Statement

This news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of The Evermedia Group, Inc. and its subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to statements of the plans, strategies and objectives of management for future operations, including execution of growth strategies, transformation initiatives and restructuring plans; any statements concerning expected development, performance or market share relating to products and services; any statements regarding anticipated operational and financial results; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. Risks, uncertainties and assumptions include macroeconomic and geopolitical trends and events; the competitive pressures faced by Evermedia's businesses; the development and transition of new products and services
'/>"/>

SOURCE Evermedia Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. MiMedx Group, Inc. Announces Release Date for 2010 Fourth Quarter and Full Year Results
2. The PMI Group, Inc. Announces Pricing of Common Stock and Convertible Senior Notes Offerings
3. Native Americans descended from a single ancestral group, DNA study confirms
4. UCSB scientists make advances in neuroscience and vision research
5. Bats, dolphins, and mole rats inspire advances in ultrasound technology
6. CHEO scientist advances biotherapeutics as published in Cancer Cell
7. New technique advances bioprinting of cells
8. Molecular technique advances soybean rust resistance research
9. Latest advances in gene therapy for ocular disease are highlighted in Human Gene Therapy
10. Advances in HIV/AIDS prevention and treatment
11. NYU Langone experts present advances at American Association of Neurological Surgeons Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... from the University of Texas Medical Branch at Galveston has ... antibodies can completely protect monkeys against a lethal dose of ... time when the disease is severe. , Thomas Geisbert, professor ... Nature discussing advances in Ebola treatment research. The filoviruses ... most deadly of pathogens, with fatality rates of up to ...
(Date:8/29/2014)... the repeated climatic shifts over the last 120,000 ... diversity, a team of researchers led by City ... developed a new biodiversity metric called "phylogeographic endemism." ... genetic variation within species is restricted in geographical ... biology, and 14 other researchers from institutions in ...
(Date:8/29/2014)... explored the type and number of connections in transcription ... on robustness in a study published in PLOS ... that the assortativity signature contributes to a network,s resilience ... varying the out-out assortativity of TFN models has a ... other three types of assortativity," said Dov A. Pechenick, ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2CCNY team defines new biodiversity metric 2Assortativity signatures of transcription factor networks contribute to robustness 2
... have manipulated cell activity that occurs during the interruption ... animal studies. The finding has the potential to become ... already existing drugs might be pressed into service to ... ischemia, is a major problem in many organs, where ...
... science may be a significant step closer to climbing into ... researchers at Washington University School of Medicine in St. Louis ... that a single protein, HS1, enables key functions of natural ... viral infections. The protein allows the NK cells to pursue ...
... fossil and the reinterpretation of previously known fossils, all from ... "missing link" in the evolution of flatfishes and explain one ... include halibut, flounder and sole, have a bizarre structural adaptation: ... is even more remarkable is that every flatfish is born ...
Cached Biology News:Novel approach may protect against heart attack injury 2Control switches found for immune cells that fight cancer, viral infection 2New fossil tells twisted tale of how flatfishes ended up with two eyes on one side of head 2New fossil tells twisted tale of how flatfishes ended up with two eyes on one side of head 3New fossil tells twisted tale of how flatfishes ended up with two eyes on one side of head 4
(Date:8/28/2014)... Whitehouse Laboratories is excited to announce ... PTI Inspection Systems that will enable it ... art leak testing method development and validation programs using ... As part of this agreement, Whitehouse Labs has taken ... Instrument developed and manufactured by PTI. The HVLD ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics that address ... disorders, announced today that it has filed a registration ... Exchange Commission (SEC) relating to the proposed initial public ... of shares to be offered and the price range ... Citigroup and Cowen and Company will act as ...
(Date:8/27/2014)... DENVER , Aug. 27, 2014   MSC ... and patient safety, today announced the appointment of ... With 28 years of experience preparing companies ... in 2013 as Executive Vice President of Corporate Development ... healthcare performance improvement business , as well as corporate ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Chelating Agents Market 2014-2018 ... About Chelating Agent A chelating agent is a ... metal ions, thereby forming a metal-ion complex. It ... on chemical processes, formulations, and the environment by ...
Breaking Biology Technology:Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4
... one of the largest provider of integrated and customized ... and investors that, on April 10, 2008, the National ... 264,000 m3 of,biodiesel, for delivery between July 1 and ... ensure supply of the necessary volumes for the,mandatory blend ...
... LAUSANNE, Switzerland, April 11 Galderma Pharma ... dermatology, today,announced that its U.S. holding company, ... CollaGenex Pharmaceuticals, Inc. (Nasdaq:,CGPI). As a result ... wholly owned,subsidiary of Galderma Laboratories., "We ...
... international start-up, CEOs, business development executives, and service providers ... ... the globe, MASSAPEQUA, N.Y. and CLEVELAND, April ... BioEnterprise Corporation, the Cleveland-based bioscience business,formation, recruitment, and acceleration initiative, ...
Cached Biology Technology:Galderma Completes Acquisition of CollaGenex 2Galderma Completes Acquisition of CollaGenex 3Galderma Completes Acquisition of CollaGenex 4IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference 2IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference 3
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Rac 1/2/3/4 (S-18)...
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
Biology Products: